切换至 "中华医学电子期刊资源库"

中华结直肠疾病电子杂志 ›› 2013, Vol. 02 ›› Issue (05) : 214 -216. doi: 10.3877/cma.j.issn.2095-3224.2013.05.01.

所属专题: 文献

述评

低位直肠癌的治疗
李政昌1()   
  1. 1. 70403 台南,成功大学医学院附设医院外科部
  • 收稿日期:2013-08-15 出版日期:2013-10-25
  • 通信作者: 李政昌

The treatment of low rectal cancer

Zheng-chang LI1,()   

  1. 1. Division of Colorectal Surgery, Department of Surgery, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan
  • Received:2013-08-15 Published:2013-10-25
  • Corresponding author: Zheng-chang LI
  • About author:
    Corresponding author: LI Zheng-chang, Email:
引用本文:

李政昌. 低位直肠癌的治疗[J]. 中华结直肠疾病电子杂志, 2013, 02(05): 214-216.

Zheng-chang LI. The treatment of low rectal cancer[J]. Chinese Journal of Colorectal Diseases(Electronic Edition), 2013, 02(05): 214-216.

从1998年开始,针对低位直肠癌,成功大学附属医院结直肠癌治疗团队一直使用术前放射及化学治疗,之后再行手术治疗,同时建造保护性肠造口。术后加以辅助化疗,化疗疗程结束后,再将肠道造口关闭。十年来,大多数患者都能顺利完成治疗且都存活至今,在此介绍我们的治疗经验。

Since 1998, the multidisciplinary team of colorectal cancer started to perform neoadjuvant radiochemotherapy for lower rectal cancer.For every patient who completed the neoadjuvant radiochemotherapy treatment course, total mesorectal excision with defunctioning colostomy or ileostomy would be done.After completion of post-operative adjuvant chemotherapy, the defunctioning colostomy or ileostomy would be closed surgically.We presented our treatment results here.

[1]
Heald RJ,Husband EM,Ryall RDH.The mesorectum in rectal cancer surgery—the clue to pelvic recurrence?British Journal of Surgery,1982,69(10):613-616.
[2]
Sauer R,Liersch T,Merkel S,et al.Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer:results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years.Journal of Clinical Oncology,2012,30(16):1926-1933.
[3]
Bosset J F,Collette L,Calais G,et al.Chemotherapy with preoperative radiotherapy in rectal cancer.New England Journal of Medicine,2006,355(11):1114-1123.
[4]
Wagman R,Minsky BD,Cohen AM,et al.Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis:long term follow-up.International Journal of Radiation Oncology Biology Physics,1998,42(1):51-57.
[5]
Lin SC,Chen PC,Lee CT,et al.Routine defunctioning stoma after chemoradiation and total mesorectal excision:a single-surgeon experience.WJG,2013,19(11):1797.
[6]
Moore HG,Riedel E,Minsky BD,et al.Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy.Annals of Surgical Oncology,2003,10(1):80-85.
[7]
Quirke P,Dixon MF,Durdey P,et al.Local recurrence of rectal adenocarcinoma due to inadequate surgical resection:histopathological study of lateral tumour spread and surgical excision.The Lancet,1986,328(8514):996-999.
[8]
Gosens MJEM,Klaassen RA,Tan-Go I,et al.Circumferential margin involvement is the crucial prognostic factor after multimodality treatment in patients with locally advanced rectal carcinoma.Clinical Cancer Research,2007,13(22):6617-6623..
[9]
Bernstein TE,Endreseth BH,Romundstad P,et al.Circumferential resection margin as a prognostic factor in rectal cancer.British Journal of Surgery,2009,96(11):1348-1357.
[10]
Capirci C,Valentini V,Cionini L,et al.Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer:long-term analysis of 566 ypCR patients.Int J Radiat Oncol Biol Phys,2008,72(1):99-107.
[11]
Campos-Lobato LF,Stocchi L,Luz Moreira A,et ai.Pathologic complete response after neoadjuvant treatment for rectal cancer decreases distant recurrence and could eradicate local recurrence.Ann Surg Oncol,2011,18(6):1590-1598.
[12]
Maas M,Nelemans PJ,Valentini V,et al.Long-term outcome in patients with a pathological complete response after chemoradiation for rectal cancer:a pooled analysis of individual patient data.Lancet Oncol,2010,11(9):835-844.
[13]
Ha YH,Jeong SY,Lim B,et al.Influence of preoperative chemoradiotherapy on the number of lymph nodes retrieved in rectal cancer.Annals of surgery,2010,252(2):336-340.
[14]
Klos CL,Bordeianou LG,Sylla P,et al.The prognostic value of lymph node ratio after neoadjuvant chemoradiation and rectal cancer surgery.Diseases of the Colon & Rectum,2011,54(2):171-175.
[15]
Chang GJ,Rodriguez‐Bigas MA,Eng C,et al.Lymph node status after neoadjuvant radiotherapy for rectal cancer is a biologic predictor of outcome.Cancer,2009,115(23):5432-5440.
[16]
Den Dulk M,Collette L,Van De Velde CJH,et al.Quality of surgery in T3-4 rectal cancer:involvement of circumferential resection margin not influenced by preoperative treatment.Results from EORTC trial 22921.European Journal of Cancer,2007,43(12):1821-1828.
[17]
Machado M,Hallböök O,Goldman S,et al.Defunctioning stoma in low anterior resection with colonic pouch for rectal cancer.Diseases of the colon & rectum,2002,45(7):940-945.
[18]
Peeters K,Tollenaar R,Marijnen CAM,et al.Risk factors for anastomotic failure after total mesorectal excision of rectal cancer.British journal of surgery,2005,92(2):211-216.
[19]
Hüser N,Michalski CW,Erkan M,et al.Systematic review and meta-analysis of the role of defunctioning stoma in low rectal cancer surgery.Annals of surgery,2008,248(1):52-60.
[20]
Tan WS,Tang CL,Shi L,et al.Meta‐analysis of defunctioning stomas in low anterior resection for rectal cancer.British Journal of Surgery,2009,96(5):462-472.
[21]
Mirnezami A,Mirnezami R,Chandrakumaran K,et al.Increased local recurrence and reduced survival from colorectal cancer following anastomotic leak:systematic review and meta-analysis.Annals of surgery,2011,253(5):890-899.
[22]
Parc Y,Zutshi M,Zalinski S,et al.Preoperative radiotherapy is associated with worse functional results after coloanal anastomosis for rectal cancer.Diseases of the Colon & Rectum,2009,52(12):2004-2014.
[23]
Joo JS,Latulippe JF,Alabaz O,et al.Long-term functional evaluation of straight coloanal anastomosis and colonic J-pouch.Diseases of the colon & rectum,1998,41(6):740-746.
[24]
Rivera S,Villa J,Quero L,et al.Adjuvant radiotherapy for rectal cancer:recent results,new questions.Clinics and research in hepatology and gastroenterology,2011,35(1):17-22.
[25]
Dionisi F,Musio D,Raffetto N,et al.Preoperative intensified radiochemotherapy for rectal cancer:experience of a single institution.Int J Colorectal Dis,2011,26(2):153-164.
[26]
Valentini V,De Paoli A,Gambacorta MA,et al.Infusional 5-fluorouracil and ZD1839(Gefitinib–Iressa)in combination with preoperative radiotherapy in patients with locally advanced rectal cancer:a phase I and II trial(1839IL/0092).International Journal of Radiation Oncology Biology Physics,2008,72(3):644-649.
[1] 代莉, 邓恢伟, 郭华静, 黄芙蓉. 术中持续输注艾司氯胺酮对腹腔镜结直肠癌手术患者术后睡眠质量的影响[J]. 中华普通外科学文献(电子版), 2023, 17(06): 408-412.
[2] 王得晨, 杨康, 杨自杰, 归明彬, 屈莲平, 张小凤, 高峰. 结直肠癌微卫星稳定状态和程序性死亡、吲哚胺2,3-双加氧酶关系的研究进展[J]. 中华普通外科学文献(电子版), 2023, 17(06): 462-465.
[3] 唐旭, 韩冰, 刘威, 陈茹星. 结直肠癌根治术后隐匿性肝转移危险因素分析及预测模型构建[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 16-20.
[4] 张生军, 赵阿静, 李守博, 郝祥宏, 刘敏丽. 高糖通过HGF/c-met通路促进结直肠癌侵袭和迁移的实验研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 21-24.
[5] 张焱辉, 张蛟, 朱志贤. 留置肛管在中低位直肠癌新辅助放化疗后腹腔镜TME术中的临床研究[J]. 中华普外科手术学杂志(电子版), 2024, 18(01): 25-28.
[6] 李婷, 张琳. 血清脂肪酸代谢物及维生素D水平与结直肠癌发生的关系研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 661-665.
[7] 付振保, 曹万龙, 刘富红. 腹腔镜直肠癌低位前切除术中不同缝合方法的回肠双腔造口术临床效果研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 684-687.
[8] 贺亮, 王松林, 周业江. 两种预防性回肠造口在腹腔镜ISR术治疗超低位直肠癌的效果对比研究[J]. 中华普外科手术学杂志(电子版), 2023, 17(06): 697-700.
[9] 倪文凯, 齐翀, 许小丹, 周燮程, 殷庆章, 蔡元坤. 结直肠癌患者术后发生延迟性肠麻痹的影响因素分析[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 484-489.
[10] 范小彧, 孙司正, 鄂一民, 喻春钊. 梗阻性左半结肠癌不同手术治疗方案的选择应用[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 500-504.
[11] 杨红杰, 张智春, 孙轶. 直肠癌淋巴结转移诊断研究进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 512-518.
[12] 马慧颖, 凡新苓, 覃仕瑞, 陈佳赟, 曹莹, 徐源, 金晶, 唐源. 磁共振加速器治疗局部晚期直肠癌的初步经验[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 519-523.
[13] 关旭, 王锡山. 基于外科与免疫视角思考结直肠癌区域淋巴结处理的功与过[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 448-452.
[14] 顾睿祈, 方洪生, 蔡国响. 循环肿瘤DNA检测在结直肠癌诊治中的应用与进展[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 453-459.
[15] 卢艳军, 马健, 白鹏宇, 郭凌宏, 刘海义, 江波, 白文启, 张毅勋. 纳米碳在腹腔镜直肠癌根治术中253组淋巴结清扫的临床效果[J]. 中华结直肠疾病电子杂志, 2023, 12(06): 473-477.
阅读次数
全文


摘要